CVE-2026-62218 — HIGH (8.8)

Q: How severe is CVE-2026-62218?

CVE-2026-62218 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2026-62218?

Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.

Vulnerability Description

OpenClaw 2026.1.20 before 2026.5.27 contain an authorization bypass vulnerability in the device.pair.approve feature that allows lower-trust callers to bypass role-management checks. Attackers can perform actions requiring stronger authorization by reaching the affected feature through configured input paths.

CVSS Score

8.8

HIGH

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

LOW

User Interaction

NONE

Scope

UNCHANGED

Confidentiality

HIGH

Integrity

HIGH

Availability

HIGH

Affected Products

Vendor	Product	Versions
Openclaw	Openclaw	>= 2026.1.20, < 2026.5.27

Related Weaknesses (CWE)

CWE-862

References

https://github.com/openclaw/openclaw/security/advisories/GHSA-8v95-qqcm-qp9hVendor Advisory
https://www.vulncheck.com/advisories/openclaw-authorization-bypass-via-device-paThird Party Advisory

FAQ

What is CVE-2026-62218?

CVE-2026-62218 is a vulnerability with a CVSS score of 8.8 (HIGH). OpenClaw 2026.1.20 before 2026.5.27 contain an authorization bypass vulnerability in the device.pair.approve feature that allows lower-trust callers to bypass role-management checks. Attackers can per...

How severe is CVE-2026-62218?

CVE-2026-62218 has been rated HIGH with a CVSS base score of 8.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2026-62218?

Check the references section above for vendor advisories and patch information. Affected products include: Openclaw Openclaw.